Financials·Life & Health Insurance·$5.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.22 | N/A | -8.37% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.22 | N/A | -8.37% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management acknowledged the difficulties impacting performance this quarter. They emphasized a commitment to addressing operational challenges.
We are facing ongoing challenges in our operating environment.
Our focus remains on improving our cost structure and member experience.
Oscar Health's earnings report reveals a larger-than-expected loss per share, which contributed to a significant drop in stock price. Investors reacted negatively, likely due to concerns about the company's ongoing operational challenges and lack of revenue data. The absence of guidance further adds to uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERTEX PHARMACEUTICA
Nov 4, 2024